NanoView Awarded Phase II SBIR Grant from the National Science Foundation

Phase II grant to support development of innovative exosome characterization platform BOSTON, Sept. 27, 2018 /PRNewswire/ — NanoView Biosciences, an emerging leader in the field of exosome characterization, has been awarded a National Science Foundation Small Business Innovation Research Phase II grant in the amount of $750,000. The program will focus on completing development of the ExoView™ system, the company’s... Read more

NanoView Biosciences Appoints Jerry Williamson as Chief Executive Officer

Company prepares for commercial launch of its innovative products for detection and characterization of Exosomes Boston, MA- NanoView Biosciences, (“NanoView” or the “Company”), an emerging leader in commercializing high value exosome-associated products, today announced that Jerry Williamson has been named as the Company’s new Chief Executive Officer effective July 1, 2018, and continues as a... Read more